ReNeuron Announces Market Launch Of ReNcell

Guildford, UK, 20 November 2006: ReNeuron Group plc (LSE: RENE.L) and Millipore Corporation (NYSE: MIL), announce the market launch of ReNeuron's patented ReNcellTM neural stem cell lines for non-therapeutic applications. These products are the only immortalised human somatic neural stem cell lines on the market today.

Back to news